Predictive validity of the model for calculating of echocardiographic parameters in healthy patients by A. A. Sokolov, M. V. Soldatenko, A. V. Smorgon

Get full text

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction by E. V. Grakova, K. V. Kopeva, A. T. Teplyakov, M. V. Soldatenko, T. E. Suslova, V. V. Kalyuzhin

Get full text

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocar... by E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko

Get full text

Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test by E. V. Grakova, K. V. Kopieva, А. T. Teplyakov, O. N. Ogurkova, M. V. Soldatenko, A. A. Garganeeva

Get full text

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction by K. V. Kopeva, A. N. Maltseva, E. V. Grakova, A. V. Mochula, M. V. Soldatenko, V. V. Kalyuzhin, K. V. Zavadovsky

Get full text

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction by K. N. Vitt, E. A. Kuzheleva, O. V. Tukish, M. V. Soldatenko, M. Yu. Kondratiev, O. N. Ogurkova, T. E. Suslova, A. A. Garganeeva

Get full text